TrialSpark stands with the Black community against racism, hate, and systemic injustice.
The recent deaths of George Floyd, Ahmaud Arbery, Breonna Taylor and so many others represent the latest manifestation of the longstanding racial and systemic inequities that exist in our country.
At TrialSpark, we are committed to taking action to create a more just and equitable world. In healthcare, we as an industry have a very long way to go. Black, Hispanic, and indigenous populations experience not only significant disparities in access to treatments, but also in outcomes. Black communities are grossly underrepresented in clinical trials, resulting in drugs on the market that may have differentiated efficacy based on race and gender. We plan to use our platform as a vehicle for change in our industry.
As a company, we are committing to:
- Educating our investigators (doctors) in order to increase awareness around the challenges that BIPOC (Black, Indigenous and people of color) communities face
- Reaching new patient populations in order to democratize access to clinical trials for minority groups
- Expanding the diversity of our investigators. In the near term, we will be rolling out targeted initiatives to expand trials that are more inclusive and representative of all communities.
TrialSpark understands that violence perpetuated upon the Black community is not limited solely to police brutality. Unequal access to healthcare is also a form of violence that disproportionately impacts minority communities. We are committed to dismantling these systemic disparities in our healthcare system so that everyone is guaranteed a fair fight and equal opportunities on their journey to good health.